methylprednisolone has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Jiang, Y; Sheng, N; Yang, X | 1 |
| Antaya, RJ; Li, AW; Stamey, CR; Subtil, A; Tomayko, MM; Weed, JG | 1 |
| Körber, A; Sondermann, W; Wehrmann, C | 1 |
| Bohmová, J; Jedlickova, H; Sirotkova, A | 1 |
| Astill, D; Marshman, G; Ryan, E | 1 |
| ber Rahman, S | 1 |
| Aydogan, K; Balaban Adim, S; Karadogan, S; Tunali, S | 1 |
| Bruch-Gerharz, D; Haust, M; Homey, B; Meller, S | 1 |
| Kind, P; Meurer, M; Schirren, CG; Storck, R | 1 |
| Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K | 1 |
| Becvár, R; Hercogová, J; Mandys, V; Petrovská, P; Pock, L | 1 |
2 review(s) available for methylprednisolone and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature.
Topics: Biopsy, Needle; Drug Therapy, Combination; Erythema Multiforme; Female; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Risk Assessment; Severity of Illness Index; Sjogren's Syndrome; Treatment Outcome | 2005 |
[Papular mucinosis. A rare cutaneous manifestation of lupus erythematosus].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Indomethacin; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Mucinoses; Skin | 1994 |
9 other study(ies) available for methylprednisolone and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Biopsy; Diagnosis, Differential; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Methylprednisolone | 2020 |
Bullous systemic lupus erythematosus in a 6-year-old boy.
Topics: Child; Enzyme Inhibitors; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Methylprednisolone; Mycophenolic Acid; Skin; Skin Diseases, Vesiculobullous | 2017 |
[Secukinumab-induced subacute-cutaneous lupus erythematosus].
Topics: Administration, Cutaneous; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biopsy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Lupus Erythematosus, Cutaneous; Methylprednisolone; Middle Aged; Photosensitivity Disorders; Psoriasis; Skin | 2018 |
Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
Topics: Adult; Blister; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone | 2008 |
Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus.
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Cutaneous; Methylprednisolone; Middle Aged; Stevens-Johnson Syndrome | 2012 |
Lupus tumidus: a variant of cutaneous lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Chloroquine; Chronic Disease; Female; Humans; Lupus Erythematosus, Cutaneous; Methylprednisolone; Sunscreening Agents; Treatment Outcome | 2004 |
[Light induced subacute cutaneous lupus erythematodes: diagnosis and management].
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Basement Membrane; Chloroquine; Drug Therapy, Combination; Epithelium; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Photosensitivity Disorders; Skin; Tacrolimus | 2007 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous | 1996 |
Verrucous form of chilblain lupus erythematosus.
Topics: Biopsy, Needle; Chilblains; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Hydroxychloroquine; Keratosis; Lupus Erythematosus, Cutaneous; Methylprednisolone; Middle Aged; Mouth Mucosa; Risk Assessment; Treatment Outcome | 2001 |